ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
March 06 2008 - 6:00AM
PR Newswire (US)
Conference call scheduled for March 13, 2008 at 1:30 p.m.
(Pacific); simultaneous webcast at www.adventrx.com SAN DIEGO,
March 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc.
(AMEX:ANX) today announced that it will host a conference call and
webcast on Thursday, March 13th, 2008 at 1:30 p.m. Pacific / 4:30
p.m. Eastern to discuss fourth quarter and year end 2007 results.
Evan M. Levine, chief executive officer and president of ADVENTRX,
will host the conference call. The conference call may be accessed
by dialing (800) 896-8445 for domestic callers and (785) 830-1916
for international callers. The webcast will be available live via
the Internet by accessing ADVENTRX's web site at
http://www.adventrx.com/ under "Investors". Replays of the webcast
will be available for 30 days on ADVENTRX's web site, and a phone
replay will be available through March 18, 2008 by dialing (888)
203-1112 and entering the passcode 3804583. About ADVENTRX
Pharmaceuticals ADVENTRX Pharmaceuticals is a biopharmaceutical
research and development company focused on commercializing
proprietary product candidates for the treatment of cancer and
infectious diseases. The Company seeks to improve the performance
and safety of existing treatments by addressing significant
problems, such as drug metabolism and bioavailability, excessive
toxicity and treatment resistance. More information can be found on
ADVENTRX's web site at http://www.adventrx.com/. DATASOURCE:
ADVENTRX Pharmaceuticals CONTACT: Investors, Ioana C. Hone of
ADVENTRX Pharmaceuticals, +1-858-552-0866 Web site:
http://www.adventrx.com/
Copyright
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jul 2023 to Jul 2024